<DOC>
	<DOC>NCT00631046</DOC>
	<brief_summary>The objective of this intervention study is to examine the effect of n-3 LCPUFA on growth and body composition, intestinal health and microbiotic composition, immune function and risk markers for later diseases in 9-18 months old infants and toddlers.</brief_summary>
	<brief_title>Essential Fatty Acids During Complementary Feeding</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Singleton infants, 9 mo +/ 2 wk, born &gt;= 37 wk of gestation Birth weight &gt;=2500g, a 5min Apgar score &gt;= 7, birth weight &gt;= 5th percentile for gestational age Chronic diseases expected to influence growth and dietary intake Use of medicine expected to influence growth and dietary intake Fish oil supplementation</criteria>
	<gender>All</gender>
	<minimum_age>8 Months</minimum_age>
	<maximum_age>19 Months</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>n-3 LCPUFA</keyword>
	<keyword>Fish oil</keyword>
	<keyword>essential fatty acids</keyword>
	<keyword>infant growth</keyword>
	<keyword>obesity</keyword>
	<keyword>Intestinal microbiota</keyword>
</DOC>